Myricx Pharma Limited
12082645
Some Concerns
- No accounts filed in last 18 months (-5)
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 29/10/2019
VENTURE CAPITALIST
BRITISH · UNITED KINGDOM · Age 54
Also on 4 other boards
director · Since 19/04/2023
VENTURE CAPITALIST
BRITISH · UNITED KINGDOM · Age 43
Also on 3 other boards
director · Since 10/11/2023
ENGINEER
BRITISH · SWITZERLAND · Age 67
Also on 2 other boards
Persons with Significant Control
Former PSCs
Professor Edward William Tate
Ceased 30/10/2019
CompanyRankvs 22900+ SIC 72110 peers39
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/07/2023
Net Worth
-£3.7M
Balance sheet strength
Cash
£985k
Cash in the bank
Net Current Assets
-£3.7M
Working capital
Current Assets
£1.6M
Current Liabilities
£5.3M
Fixed Assets
£47k
Debtors
£608k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 0.30 | -£2.5M |
| 2022 | 7.95 | -£2.6M |
| 2021 | 10.91 | -£338k |
| 2020 | 13.23 | — |
Derived from filed accounts. Not audited figures.